Medicis Lab-Derived Dermal Filler On Track For Year-End Approval – Exec
This article was originally published in The Gray Sheet
Executive Summary
Medicis will hire a 30-40 rep sales force for Q-Med's Restylane non-animal stabilized hyaluronic acid (NASHA)-based surgical wrinkle treatment in time for the product's launch, anticipated by 2004